Porogaramu ya DTP ya CaryHealth yoroshya uburyo bwo kuvura bwa Natroba (echinococcin) ikoresha uburyo butandukanye bwo kwita ku barwayi hakoreshejwe interineti, ibukoresha mu buryo bunoze kandi bugamije kwita ku barwayi.
WASHINGTON, 7 Mata 2026 — (BUSINESS WIRE) — CaryHealth, ikigo gikomeye mu by’ubuzima bushingiye ku ikoranabuhanga, uyu munsi cyatangaje ubufatanye na Cipher Pharmaceuticals US LLC (Cipher cyangwa Cipher Pharmaceuticals) mu gutangiza urubuga rwayo rwo kugera ku barwayi (DTP), rugamije korohereza abarwayi kubona umuti wanditswe na muganga witwa Natroba (spinosad), ukoreshwa mu kuvura inda zo mu mutwe n’ibihumyo. Muri ubu bufatanye, CaryHealth yateguye urubuga rwo kuri interineti rutuma abarwayi babona vuba kandi bakatora Natroba (spinosad), bikuraho imbogamizi abarwayi bahura nazo iyo bakoresha serivisi z’ubuzima zikoreshwa kuri interineti.
“Imiryango ihura n’ibisebe n’ibihumyo ikeneye igisubizo cyihuse kandi cyoroshye kugira ngo ibone imiti myiza kandi ikora neza,” ibi byavuzwe na Brian Jacobs, Perezida w’ibikorwa bya Cipher Pharmaceuticals muri Amerika. “Binyuze mu bufatanye bwacu na CaryHealth, dutanga serivisi zo gufata imiti cyangwa kuyigeza mu rugo, bityo byorohereza kandi byihuse abarwayi kubona Natroba™ cyangwa verisiyo yayo yemewe, spinosad. Imiti gakondo yo muri farumasi ntabwo igikora, ariko Natroba™ (spinosad) itanga ubutabazi bwihuse ku bisebe n’ibihumyo.”
“Cipher iri gutera intambwe ikomeye kandi yibanda ku barwayi ishora imari mu buryo bw’ubuvuzi bw’ikoranabuhanga buhuriweho,” ibi byavuzwe na Areo Nazari, Umuyobozi Mukuru wa CaryHealth. “Mu guhuza imiti itangwa n’abaganga, imikoranire n’abaganga, na serivisi za farumasi (harimo no gutanga serivisi) mu buryo bumwe, dushobora gufasha imiryango gusubira mu buzima busanzwe, kuva igihe ikeneye ubuvuzi kugeza igihe ivuriye neza.”
CaryHealth yateguye igisubizo cyuzuye, gisobanutse kandi cyuzuye cyo kwita ku barwayi ba Natroba™ (echinococcin), gifasha mu kunoza uburyo bwo kwita ku barwayi muri rusange binyuze mu kugabanya igihe cyo kubona serivisi no gukuraho inzitizi. Iki gisubizo gikuraho inzira zitari zo zoroshye zo kwita ku barwayi kuri interineti, kwinjira mu buryo bwinshi, no kwishyura mu buryo butandukanye, giha abarwayi uburyo bwo kubona imiti ijyanye n'ubuvuzi bari kure, kwishimira koherezwa ku munsi umwe muri farumasi mu gihugu hose mu gace ka serivisi ya CaryRx, no gukurikirana uko imiti ihagaze mu gihe nyacyo binyuze kuri urubuga rwa CaryConnect.
CaryHealth ni ikigo gishinzwe ikoranabuhanga mu by'imiti n'ubuvuzi gikoresha ubwenge bw'ubukorano kugira ngo gihindure uburyo abarwayi batangira kandi bagakurikiza amabwiriza y'ubuvuzi. Urubuga rwacu ruhuza serivisi za farumasi, ikoranabuhanga mu buryo bwikora, n'uburyo bwo gukoresha amakuru kugira ngo kunoze uburyo bwo kwivuza, kunoza uburyo ubuvuzi bukomeza, no guha imbaraga abarwayi mu gihe cyose cyo kuvurwa. Mu kuziba icyuho kiri hagati y'ubumenyi bw'ubuzima, abatanga serivisi z'ubuvuzi, n'abarwayi, CaryHealth iteza imbere uburyo bungana bwo kubona ibikoresho by'ubuvuzi kandi igafasha ubuvuzi butandukanye kugera ku bushobozi bwabwo bwose.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) ni ikigo cyihariye cy’imiti cyibanda ku buvuzi bw’uruhu gifite urutonde rw’ibicuruzwa n’ibicuruzwa byinshi byagurishijwe mu ntangiriro no mu za nyuma. Cipher topical Natroba™ hamwe na verisiyo yayo yemewe, spinosad, ni byo bicuruzwa byonyine byahawe izina "risobanutse" ry’ibihumyo n’Ikigo gishinzwe ibiribwa n’imiti cya Amerika (FDA). Byongeye kandi, Natroba™ (spinosad) ni wo muti wonyine wemejwe na FDA ku ndwara z’imitsi yo mu mutwe wagaragaje ubushobozi bwo kuvura neza ugereranije na Nix® (1% permethrin) mu igeragezwa ry’icyiciro cya gatatu. Nta gukamura amagi y’imitsi ari ngombwa.
Igihe cyo kohereza: 28 Mata 2026
